Skip to main navigation Skip to search Skip to main content

Use of the p2l/WAF1 promoter for transcriptional targetting in cancer gene therapy

  • Helen McCarthy
  • , J. Worthington
  • , C. Ward
  • , E. Barrett
  • , David Hirst
  • , S.R. McKeown
  • , Tracy Robson

Research output: Contribution to conferencePaperpeer-review

Original languageEnglish
PagesS29-S29
Number of pages1
Publication statusPublished - Mar 2004
EventBritish Society of Gene Therapy - Oxford, London, United Kingdom
Duration: 28 Mar 200430 Mar 2004

Conference

ConferenceBritish Society of Gene Therapy
Country/TerritoryUnited Kingdom
CityLondon
Period28/03/200430/03/2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this